Ocular Therapeutix says it won a reimbursement code for the insertion of its drug-eluting intracanalicular plugs.
Ocular Therapeutix said it landed a reimbursement code for the insertion of the drug-eluting eye plugs it's developing to treat glaucoma.
Bedford, mass.-based Ocular Therapeutix said the American Medical Assn. issued a CPT code "for the insertion of a drug-eluting implant, including punctal dilation and implant removal when performed, into the lacrimal canaliculus."
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1kisFcq
Cap comentari:
Publica un comentari a l'entrada